Abstract-The aim of this meta-analysis was to estimate the diagnostic performance of shear wave elastography (SWE) in differentiating malignant from benign breast lesions. A literature search of PubMed, Web of Science and Scopus up to November 2014 was conducted. A summary receiver operating characteristic curve was constructed, and pooled weighted estimates of sensitivity and specificity were calculated using a bivariate mixed-effects regression model. Thirty-three studies, which included a total of 5838 lesions (2093 malignant, 3745 benign) from 5397 patients, were finally analyzed. Summary sensitivity and specificity were 0.886 (95% confidence interval [CI], 0.858-0.909) and 0.866 (95% CI, 0.833-0.894), respectively. The pooled diagnostic odds ratio was 50.410 (95% CI, 34.972-72.664). And the area under the receiver operating characteristic curve of SWE was 0.94 (95% CI, 0.91-0.96). No publication bias existed among these studies (p 5 0.245). In the subgroup analysis, sensitivity and specificity were 0.862 (95% CI, 0.811-0.901) and 0.875 (95% CI, 0.793-0.928) among 1552 lesions from 1429 patients in the 12 studies using acoustic radiation force impulse imaging and 0.897 (95% CI, 0.863-0.923) and 0.863 (95% CI, 0.831-0.889) among another 4436 lesions from 4097 patients in the 21 studies using supersonic shear imaging. When analysis confined to 9 studies evaluated the diagnostic performance of combination SWE and conventional ultrasound, the area under the curve was 0.96 (95% CI, 0.94-0.97), yielding a sensitivity of 0.971 (95% CI, 0.941-0.986) and specificity of 0.801 (95% CI, 0.733-0.856). SWE seems to be a good quantitative method for differentiating breast lesions, with promise for integration into routine imaging pro-
INTRODUCTION
Ultrasound (US) is widely used to distinguish malignant from benign breast lesions (Raza and Baum 1997) . Compared with other early detection methodologies, US provides several advantages in breast cancer, including high spatial resolution, real-time imaging and low cost. The Breast Imaging Reporting and Data System (BI-RADS) for US has served as the standardized terminology for the assessment of breast lesions. Although US has high accuracy in the detection of breast lesions, it does not perform as well in differentiating malignant from benign lesions because its diagnostic specificity is relatively low.
With advances in US technology, strain elastography has emerged as a new imaging technique that can measure tissue stiffness as additional diagnostic information. In many commercial implementations, strain elastography presents tissue stiffness information in a color map superimposed on the real-time gray-scale ultrasound image. Previous studies have found that strain elastography is effective in the detection of breast cancer (Gong et al. 2011; Itoh et al. 2006 ). However, strain elastography can only qualitatively or semiquantitatively assess tissue stiffness.
Shear wave elastography (SWE) is a group of novel ultrasound-based elasticity technologies that allow the quantitative measurement of tissue stiffness. Instead of using external compression, commercially available US scanners are used to generate short-duration acoustic radiation forces that impart small (1-10 mm) localized tissue displacements, which are correlated with the local stiffness of the tissue. These displacements result in shear wave propagation and are tracked to calculate the shear wave velocity (SWV) or are converted to Young's moduli Meng et al. 2011) . In 2014, three medical ultrasound companies were offering quantitative shear wave elastography products: Siemens acoustic radiation force impulse (ARFI) quantification, Supersonic Imagine supersonic shear imaging (SSI) and Philips ElastPQ. However, shear wave elastography for breast imaging was available only on Siemens' and Supersonic Imagine's systems. In ARFI imaging, a sequence of rapid bursts of focused ultrasound pulses is generated to create a localized displacement of a few microns, which generates transient shear wave propagation with cylindrical symmetry away from the pushing-beam's axis. The shear displacement is along the ultrasound imaging beam, allowing the use of correlation tracking or Doppler to measure the small displacements of the shear wave and detect the time it arrives at lateral positions (Bamber et al. 2013) . In SSI, the acoustic radiation force focus is swept down the acoustic axis faster than the shear wave speed to generate tissue displacements at all positions along the acoustic axis almost simultaneously. This procedure induces a shear wave that spreads less and thus decays less rapidly with distance than does a single pushing focus in ARFI. Plane wave transmission for shear wave tracking improves the frame rate of shear wave up to 20 Hz. The high frame rate allows the shear waves to be followed in real time in two dimensions, and the time of arrival is detected to create images of shear wave speed or converted to images of Young's moduli (Bamber et al. 2013) .
Several studies with relatively small patient populations have obtained promising results for SWE in the differentiation of breast lesions. Although Li et al. (2013) performed a meta-analysis to summarize the diagnostic performance of SWE in the differentiation of breast lesions, only nine studies were searched and analyzed. Recently, more studies have focused on SWE in distinguishing malignant from benign breast lesions. Hence, to improve the assessment of diagnostic accuracy, we performed a new meta-analysis to investigate the diagnostic performance of SWE, including ARFI and SSI techniques, in predicting malignant breast lesions. In addition, the summary diagnostic performance of SWE added to conventional US was assessed in the metaanalysis.
METHODS

Search strategy
PubMed, Web of Science and Scopus databases were systematically searched for peer-reviewed studies through November 2014. The following Medical Subject Headings and text search terms were used: shear wave elastography, SWE, acoustic radiation force impulse, ARFI, supersonic shear imaging or SSI, combined with breast.
Study selection
The titles and abstracts of the search results were independently reviewed by two authors (B.X.L., with 5 y of experience in breast US and 3 y of experience in breast elastography, and Y.L.Z., with 13 y of experience in breast US and 3 y of experience in breast elastography). Full texts of relevant studies were retrieved for further evaluation. The reference lists of the included studies were manually searched to identify other potentially eligible studies.
To be included in the meta-analysis, studies had to meet the following criteria: (i) published in the English language literature; (ii) quantitative analysis of characteristics of the breast lesions using SWE; (iii) study population of at least 30 patients; (iv) valid reference test used in more than 75% of the included lesions (Lijmer et al. 1999; Whiting et al. 2003); (of a large core-needle biopsy specimen or surgical specimen) and imaging and clinical follow-up of more than 2 y were considered to be valid reference standards (Peters et al. 2008 ). All of the included studies should be approved by an institutional review board, and informed consent from each participant should have been obtained. Editorials, letters to the editor, reviews, case reports and animal experimental studies were excluded. When two or more studies evaluated overlapping patient samples, only the study with the larger(est) number of patients was included.
Data extraction and quality assessment
The data collected included: year of publication, study design, number of patients, mean age, sample size, lesion diameter, percentage of symptomatic lesions, percentage of diagnoses confirmed by surgery specimen, percentage of malignant lesions, SWE technique, diameter of region of interest (ROI), cutoff value, area under the receiver operating characteristic curve (AUC), diagnostic sensitivity and diagnostic specificity. Furthermore, overall numbers of TP, TN, FP and FN data were extracted. If studies did not provide data to directly construct 2 3 2 contingency tables, they were calculated based on the diagnostic sensitivity and specificity provided in the studies.
Study quality was assessed by both independent observers (B.X.L. and Q.Y.S.) using the Quality Assessment of Studies of Diagnostic Accuracy included in Systematic Review (QUADAS-2 tool) (Whiting et al. 2011) , which is a tool for assessment of methodologic quality based on sources of bias and variation in diagnostic accuracy studies. The QUADAS-2 tool consists of four key domains: patient selection, index test, reference standard and flow and timing. Each domain is assessed in terms of risk of bias (low, high or unclear), and the first three domains relate to concerns regarding applicability. Disagreements in the evaluation of study quality between the two reviewers were resolved through discussion. If no consensus could be reached, a third reviewer (X.Y.X.) was consulted to yield the final decision.
Statistical analysis
All statistical analyses were performed using the MIDAS module of Stata, Version 12.0 (Stata, College Station, TX, USA). These raw data were further analyzed as described below. If available, analyses were stratified according to the ARFI and SSI subgroups.
Pooled diagnostic performance. We extracted or reconstructed 2 3 2 contingency tables for every study included. If the authors reported data on more than one technical measurement of the same imaging modality, a contingency table was created for the measurement with the highest diagnostic performance. Summary sensitivity, summary specificity, positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were calculated using the bivariate mixed-effects regression model. The pooled diagnostic odds ratio (DOR) was also calculated; this single overall indicator of diagnostic performance is the ratio of the odds of positivity in diseased patients to the odds of positivity in non-diseased patients (Glas et al. 2003) . Summary receiver operating characteristic (SROC) curves with 95% confidence intervals (95% CIs) were constructed to quantitatively summarize the results.
Publication bias. Publication bias describes a potential limitation, because studies describing optimistic results have a higher probability of being published compared with studies describing few or unfavorable effects. Publication bias was examined by constructing a funnel plot of the natural logarithm of DOR (lnDOR) versus the inverse of the square root of the effective sample size (1/ESS 1/2 ). Testing for publication bias was conducted by a regression of lnDOR against 1/ESS 1/2 , weighting by ESS with p , 0.05 for the slope coefficient indicating significant asymmetry (Deeks et al. 2005 ).
Heterogeneity. Heterogeneity was quantified and appropriated by using the likelihood ratio index (I 2 ). I 2 values greater than 50% were considered to indicate substantial heterogeneity relative to chance alone (Berlin 1997) . If heterogeneity existed, a metaregression analysis was performed to explore the potential sources of heterogeneity that included continent of study origin (Asian vs. non-Asian country), year of publication, study design, standard reference (pathology vs. combined pathology and follow-up), sample size, mean patient age, rate of malignant lesions, rate of symptomatic lesions, lesion-to-patient ratio, SWE technique (ARFI vs. SSI) and diagnostic parameter.
RESULTS
Search strategy and study selection
The initial search yielded 501 studies, with 153 duplicate titles. Therefore, 348 studies with title, abstract or both were screened for eligibility. After that, 288 studies were excluded for being unrelated to the research subject or review articles. Therefore, 60 potentially relevant studies were identified for further evaluation by full text. Twenty-seven studies were excluded because of only a qualitative diagnosis in 8, insufficient data in 17 and inclusion of only malignant lesions in 2. Finally, 33 eligible studies were included (Bai et al. 2012; Barr and Zhang 2014; Berg et al. 2012; Chang et al. 2011; Evans et al. 2010; Golatta et al. 2014; Gweon et al. 2013; Ianculescu et al. 2014; Jin et al. 2012; Kim et al. 2015; Klotz et al. 2014; Ko et al. 2014; Lee et al. 2013a; Meng et al. 2011; Olgun et al. 2014; Tamaki et al. 2013; Tozaki et al. 2013; Wang et al. 2013; Wojcinski et al. 2013; Xiao et al. 2013; Yao et al. 2014; Ye et al. 2013; Yoon et al. 2013a; Youk et al. 2013a; Zhou et al. 2013) . Details on study characteristics are summarized in Table 1 . No additional study was included after screening the reference lists of included studies. Figure 1 is a flowchart summarizing the process used to select the studies finally included.
Study and design characteristics
Among the 33 studies included (listed in the preceding paragraph), a total of 5397 patients (mean, 158.7; range, 33-939) 1630 (mean, 70.9; range, 12-289) were malignant and, 806 (mean, 122; range, 22-650) were benign, for a malignancy rate of 36.7%. In the ARFI subgroup, shear wave velocity (SWV) was used in all except one study that used R-SWV (ratio of SWV of lesion to SWV of surrounding normal tissue) (Ye et al. 2013 ) and another study that used SWV with the quality measure (QM) (Barr and Zhang 2014) . In the SSI subgroup, maximum elasticity was adopted to extract data in 10 studies (2-mm ROI in 8 [Berg et al. 2012; Evans et al. 2012; Lee et al. 2013a; Yoon et al. 2013a; Youk et al. 2013a] , suitable ROI in 2 [Klotz et al. 2014; Wang et al. 2013] ), mean elasticity in 4 (2-mm ROI in 2 Ko et al. 2014] and unclear ROI in 2 [Chang et al. 2011; Evans et al. 2010] ), standard deviation (SD) in 2 (suitable ROI in 1 [Gweon et al. 2013 ] and 2-mm ROI in 1 [Barr and Zhang 2014] ), elasticity ratio in 3 (2-mm ROI in 2 [Olgun et al. 2014; Youk et al. 2013b ] and suitable ROI in 1 [Xiao et al. 2013] ), the value from the computer-aided diagnosis system with unclear ROI in 1 (Xiao et al. 2014 ) and SWV within a 2-mm ROI in 1 (Youk et al. 2014) . The study design was described as prospective in 11 studies (Barr and Zhang 2014; Berg et al. 2012; Chang et al. 2011; Golatta et al. 2014; Ianculescu et al. 2014; Jin et al. 2012; Lee et al. 2013b; Olgun et al. 2014; Wang et al. 2013; Zhou et al. 2013) and retrospective in 13 studies (Evans et al. 2012; Gweon et al. 2013; Kim et al. 2015; Klotz et al. 2014; Ko et al. 2014; Lee et al. 2013a; Tozaki et al. 2013; Xiao et al. 2014; Yoon et al. 2013a Yoon et al. , 2013b Youk et al. 2013a; . In another study (Lee et al. 2014) , the cohort was divided into a development cohort (patients enrolled between March 2010 and February 2012), which was retrospectively analyzed, and a validation cohort (patients enrolled between April 2012 and October 2012), which was prospectively analyzed. In the remaining 8 studies (Bai et al. 2012; Evans et al. 2010; Meng et al. 2011; Tamaki et al. 2013; Wojcinski et al. 2013; Xiao et al. 2013; Yao et al. 2014; Ye et al. 2013) , the study could not be identified as retrospective or prospective.
The QUADAS-2 tool indicated that the included studies were of generally high methodologic quality (Table 2) .
Diagnostic accuracy
In the 33 studies cited under Search Strategy and Study Selection evaluating the diagnostic accuracy of SWE in the differentiation of benign from malignant breast lesions, the sensitivity in individual studies ranged from 50% to 100%, whereas the specificity ranged from 33% to 100% (Table 1) . Forest plots of sensitivity and specificity with 95% CIs are provided in Figure 2 . The sensitivity, specificity, PLR and NLR were 0.886 (95% CI, 0.858-0.909), 0.866 (95% CI, 0.833-0.894), 6.628 (95% CI, 5.271-8.335) and 0.131 (95% CI, 0.105-0.165), respectively. Meanwhile, the pooled DOR was 50.410 (95% CI, ). The area under the SROC curve (AUC) of SWE was 0.94 (95% CI, 0.91-0.96) (Fig. 3) .
Publication bias
Deeks' funnel plot asymmetry test produced no evidence of significant asymmetry, which meant no evidence of publication bias in these studies (p 5 0.224) (Fig. 4) .
Heterogeneity exploration
The value of I 2 was 96.48% (95% CI, 93.89%-99.07%), indicating substantial between-study heterogeneity in these studies. According to the meta-regression analysis, various factors, including the continent of study origin (p 5 0.02), mean age of patients included (p 5 0.00), mean size of lesions (p 5 0.00), rate of symptomatic lesions (p 5 0.00), and lesion-to-patient ratio (p 5 0.00) were found to be significant causes of between-study heterogeneity. Fig. 3 . Sensitivity and specificity plotted in receiver operating characteristic space for individual studies. SENS 5 sensitivity; SPEC 5 specificity; SROC 5 summary receiver operating characteristic curve; AUC 5 area under the SROC curve. Subgroup analysis between ARFI and SSI Twelve studies were included in the ARFI subgroup and another 21 studies were included in the SSI subgroup. Figure 5 are forest plots of the sensitivity and specificity of studies using ARFI. Pooled estimates for sensitivity and specificity were 0.862 (95% CI, 0.811-0.901) and 0.875 (95% CI, 0.793-0.928), respectively. The AUC was 0.92 (95% CI, 0.90-0.94) (Fig. 6a) . There was substantial between-study heterogeneity in the ARFI subgroup (I2 5 95.13%, 95% CI, 91.20%-99.06%). Among these studies, the mean cutoff value of SWV was 4.36 6 1.94 m/s.
Meanwhile, in Figure 7 are Forest plots of individual sensitivity and specificity of the studies using SSI, (Fig. 6b) . Similarly, there was substantial between-study heterogeneity in the SSI subgroup (I2 5 90.06%, 95% CI, 80.30%-99.81%).
SWE versus conventional US
Among the studies included, 21 studies compared the diagnostic performance of SWE (ARFI in 5 studies [Barr and Zhang 2014; Golatta et al. 2014; Ianculescu et al. 2014; Jin et al. 2012; Meng et al. 2011] and SSI in 16 studies [Berg et al. 2012; Chang et al. 2011; Evans et al. 2010; Klotz et al. 2014; Lee et al. 2013a Lee et al. , 2013b Wang et al. 2013; Xiao et al. 2013; Yoon et al. 2013a; Youk et al. 2013a; ) with that of conventional US. When the analysis was confined to these studies, SWE had a sensitivity of 0.903 (95% CI, 0.870-0.928) and a specificity of 0.850 (95% CI, 0.821-0.876). The AUC of SWE in 21 studies was 0.93 (95% CI, 0.91-0.95) (Fig. 8a) . Meanwhile, the sensitivity and specificity of conventional US were 0.954 (95% CI, 0.918-0.974) and 0.633 (95% CI, 0.437-0.793), respectively. The corresponding AUC was 0.94 (95% CI, 0.92-0.96) (Fig. 8b) .
Combination of SWE and US versus conventional US alone
Nine studies evaluated the diagnostic performance of SWE (ARFI in 3 studies [Golatta et al. 2014; Jin et al. 2012; Meng et al. 2011] and SSI in 6 studies [Berg et al. 2012; Evans et al. 2012; Lee et al. 2014; Wang et al. 2013; Yoon et al. 2013a; ) combined with conventional US and compared it with that of conventional US alone. When the analysis was confined to these studies, the combined diagnosis had a sensitivity of 0.971 (95% CI, 0.941-0.986) and a specificity of 0.801 (95% CI, 0.733-0.856). The AUC was 0.96 (95% CI, 0.94-0.97) (Fig. 9a) . Meanwhile, the sensitivity and specificity of conventional US in the 9 studies were 0.949 (95% CI, 0.881-0.979) and 0.552 (95% CI, 0.264-0.809), respectively. The corresponding AUC was 0.93 (95% CI, 0.90-0.95) (Fig. 9b) .
DISCUSSION
The present meta-analysis investigated the pooled diagnostic performance of SWE in the differentiation between benign and malignant breast lesions. Based on the analysis of 5838 lesions from 33 studies, it was found that SWE has high diagnostic accuracy in distinguishing malignant from benign breast lesions, with a sensitivity of 0.886 and a specificity of 0.866. The corresponding AUC was 0.94. In addition, the combination of SWE and conventional US had the highest discriminating power for the detection of a malignancy, with a corresponding AUC value of 0.96. Therefore, we deem that SWE is a good quantitative method for the differentiation of breast lesions; this method shows promise for integration into routine imaging protocols. Li et al. (2013) performed a meta-analysis to summarize the diagnostic performance of SWE in the differentiation of breast lesions, yielding summary sensitivities and specificities of 0.91 and 0.82 for SSI and 0.89 and 0.91 for ARFI, respectively. Unfortunately, only a total of 9 studies, including 1888 women and 2000 breast lesions, were analyzed. Moreover, the combined results of SWE and conventional US were not evaluated in that meta-analysis. We found that SWE is a feasible tool to differentiate malignant from benign breast lesions, providing quantitative information of stiffness. Moreover, our results suggest that the addition of SWE to Fig. 6 . Sensitivity and specificity plotted in receiver operating characteristic space for studies using acoustic radiation force impulse imaging (a) and supersonic shear imaging (b). SENS 5 sensitivity; SPEC 5 specificity;
SROC 5 summary receiver operating characteristic curve; AUC 5 area under the SROC curve.
conventional US would increase both the sensitivity and specificity. SWE is deemed a potential improvement to conventional US in the differentiation of breast lesions; it may be valuable to introduce SWE into routine clinical practice.
The studies in our meta-analysis encompassed two of the SWE modes, ARFI and SSI. Although the physical principles underlying these two elastographic techniques differ physical (Bamber et al. 2013) , they are both based on shear wave propagation in soft tissues, which is induced by an ultrasound-generated radiation force focus. Moreover, the factor of different techniques was not a significant cause of between-study heterogeneity according to meta-regression analysis. In fact, these two techniques were comparable in diagnostic performance in the differentiation of breast lesions in the subgroup analysis. Compared with ARFI, SSI improved sensitivity with a reduction in specificity, which was consistent with the meta-analysis results of Li et al. (2013) . Therefore, these two SWE techniques were included in our meta-analysis. Further studies providing patient-based comparisons between SSI and ARFI are required to explain why SSI has a higher sensitivity and a lower specificity than ARFI. As we known, various quantitative elasticity properties can be obtained directly with SSI, including mean elasticity, maximum elasticity, minimum elasticity and standard deviation in the round ROI, as well as the ratio of elasticity in the lesion and to that in the surrounding normal tissue. Moreover, ROIs of different size can be chosen. Therefore, several elastography measurements can be obtained to evaluate the stiffness of breast lesions.
In our meta-analysis, if a study reported data on more than one diagnostic parameter, the data with the highest diagnostic performance were extracted. Perhaps, maximum elasticity in a 2-mm ROI at the stiffest area of the lesions could be considered the most valuable parameter in breast lesion differentiation, and was extracted from the most studies in the SSI subgroup. Prospective multicenter trials providing patient-based comparisons between different elastography measurements of SSI are necessary.
Substantial heterogeneity was observed in the present meta-analysis. Theoretically, heterogeneity in meta-analyses may result from the search strategy and eligibility criteria used for inclusion, exposure constructs and outcome measures assessed, statistical methods employed and subgroup assessment (Genkinger and Terry 2014) . Therefore, there are many explanations for Fig. 8 . Sensitivity and specificity plotted in receiver operating characteristic space for studies comparing shear wave elastography (a) and conventional ultrasound (b). SENS 5 sensitivity; SPEC 5 specificity; SROC 5 summary receiver operating characteristic curve; AUC 5 area under the SROC curve. Fig. 9 . Sensitivity and specificity plotted in receiver operating characteristic space for studies comparing combination shear wave elastography and ultrasound (a) and conventional ultrasound alone (b). SENS 5 sensitivity; SPEC 5 specificity; SROC 5 summary receiver operating characteristic curve; AUC 5 area under the SROC curve.
the substantial heterogeneity in the meta-analysis. To date, no consensus of diagnostic criteria has been reached for SWE. Various elasticity measurements, such as shear wave velocity, shear wave velocity ratio, mean elasticity value, maximum elasticity value, minimum elasticity value, and ratio of elasticity value ratio, with different cutoff values are used. In addition, previous studies have found that the diagnostic performance of SWE is correlated with breast lesion size (Yao et al. 2014) . SWE had a relatively low sensitivity in breast lesions ,10 mm Yao et al. 2014 ). Moreover, differences may exist in the breast cancers of Asian and non-Asian women, such as difference in stiffness, although further pathologic confirmation is needed. Nevertheless, all of these could not explain the heterogeneity between the studies. Our study had some limitations. First, substantial heterogeneity in the evidence base was investigated in this meta-analysis, at both the overall and subgroup levels, which would limit recommending their integration into practice. Second, our study clearly indicates a heavy dominance of Asian studies. Because differences exist in the breast cancers of Asian and non-Asian women, multicenter prospective studies with large patient populations from different regions are necessary. Third, different cutoff values for the same technique were used for different studies in the meta-analysis because no raw data were obtained. Moreover, two SWE techniques were grouped and evaluated together. In SSI, the elasticity image is refreshed in real time. And SSI measures tissue stiffness in a larger region of interest, so it is able to provide more statistics to potentially better characterize lesion stiffness distribution. Also, in ARFI, because of the technical limitations, some SWV measurements were non-numeric values, expressed as X.XX. When the Virtual Touch quantification value was X.XX, we could not determine the true stiffness of the nodules from the numeric parameter. However, according to the meta-regression analysis, the SWE technique (ARFI vs. SSI) was found not to be a significant cause of between-study heterogeneity. Additional studies are necessary to compare different SWE techniques.
CONCLUSIONS
The present meta-analysis illustrates the high specificity and sensitivity of SWE in the differentiation of breast lesions. Thus, SWE is a reliable and noninvasive procedure that can be easily integrated into the current imaging protocols. Maximum elasticity in a 2-mm ROI at the stiffest area of the lesions could be considered the most valuable parameter. Because of the high heterogeneity, the data on reliability were insufficient.
